Filing Details

Accession Number:
0001209191-18-047102
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-08-16 17:02:02
Reporting Period:
2018-08-14
Accepted Time:
2018-08-16 17:02:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1660334 Verrica Pharmaceuticals Inc. VRCA Pharmaceutical Preparations (2834) 463137900
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1741964 Ted White C/O Verrica Pharmaceuticals Inc.
10 North High Street, Suite 200
West Chester PA 19380
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-08-14 1,905 $15.47 6,405 No 4 P Direct
Common Stock Acquisiton 2018-08-15 600 $16.40 7,005 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $15.30 to $15.57, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.